A detailed history of First Command Bank transactions in Moderna, Inc. stock. As of the latest transaction made, First Command Bank holds 1,602 shares of MRNA stock, worth $59,033. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,602
Previous 1,602 -0.0%
Holding current value
$59,033
Previous $246,000 21.14%
% of portfolio
0.02%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022

SELL
$118.07 - $194.18 $29,517 - $48,545
-250 Reduced 13.5%
1,602 $189,000
Q1 2022

Apr 14, 2022

BUY
$126.46 - $235.05 $59,056 - $109,768
467 Added 33.72%
1,852 $319,000
Q2 2021

Jul 20, 2021

BUY
$129.91 - $234.98 $50,015 - $90,467
385 Added 38.5%
1,385 $325,000
Q1 2021

Apr 20, 2021

SELL
$109.18 - $185.98 $23,582 - $40,171
-216 Reduced 17.76%
1,000 $130,000
Q4 2020

Jan 19, 2021

BUY
$65.74 - $169.86 $14,199 - $36,689
216 Added 21.6%
1,216 $127,000
Q3 2020

Oct 20, 2020

BUY
$54.34 - $94.85 $54,340 - $94,850
1,000 New
1,000 $71,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track First Command Bank Portfolio

Follow First Command Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Command Bank with notifications on news.